296 related articles for article (PubMed ID: 30192638)
61. Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions.
Büttner C; Lun A; Splettstoesser T; Kunkel G; Renz H
Eur Respir J; 2003 May; 21(5):799-803. PubMed ID: 12765424
[TBL] [Abstract][Full Text] [Related]
62. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma.
Jatakanon A; Kharitonov S; Lim S; Barnes PJ
Thorax; 1999 Feb; 54(2):108-14. PubMed ID: 10325913
[TBL] [Abstract][Full Text] [Related]
63. The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.
Leaker BR; Barnes PJ; O'Connor BJ; Ali FY; Tam P; Neville J; Mackenzie LF; MacRury T
Clin Exp Allergy; 2014 Sep; 44(9):1146-53. PubMed ID: 25040039
[TBL] [Abstract][Full Text] [Related]
64. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo.
Grünberg K; Timmers MC; Smits HH; de Klerk EP; Dick EC; Spaan WJ; Hiemstra PS; Sterk PJ
Clin Exp Allergy; 1997 Jan; 27(1):36-45. PubMed ID: 9117878
[TBL] [Abstract][Full Text] [Related]
65. Identification of genes expressed by human airway eosinophils after an in vivo allergen challenge.
Esnault S; Kelly EA; Schwantes EA; Liu LY; DeLain LP; Hauer JA; Bochkov YA; Denlinger LC; Malter JS; Mathur SK; Jarjour NN
PLoS One; 2013; 8(7):e67560. PubMed ID: 23844029
[TBL] [Abstract][Full Text] [Related]
66. CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations.
Rohde G; Message SD; Haas JJ; Kebadze T; Parker H; Laza-Stanca V; Khaitov MR; Kon OM; Stanciu LA; Mallia P; Edwards MR; Johnston SL
Clin Exp Allergy; 2014 Jul; 44(7):930-9. PubMed ID: 24673807
[TBL] [Abstract][Full Text] [Related]
67. Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab.
Nopsopon T; Barrett NA; Phipatanakul W; Laidlaw TM; Weiss ST; Akenroye A
Allergy; 2024 May; 79(5):1195-1207. PubMed ID: 38164813
[TBL] [Abstract][Full Text] [Related]
68. The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations.
Laza-Stanca V; Message SD; Edwards MR; Parker HL; Zdrenghea MT; Kebadze T; Kon OM; Mallia P; Stanciu LA; Johnston SL
PLoS Pathog; 2011 Jul; 7(7):e1002114. PubMed ID: 21779162
[TBL] [Abstract][Full Text] [Related]
69. Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab.
Pouliquen IJ; Kornmann O; Barton SV; Price JA; Ortega HG
Int J Clin Pharmacol Ther; 2015 Dec; 53(12):1015-27. PubMed ID: 26445140
[TBL] [Abstract][Full Text] [Related]
70. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
[TBL] [Abstract][Full Text] [Related]
71. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
Evans DJ; Barnes PJ; Spaethe SM; van Alstyne EL; Mitchell MI; O'Connor BJ
Thorax; 1996 Dec; 51(12):1178-84. PubMed ID: 8994512
[TBL] [Abstract][Full Text] [Related]
72. A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma.
Barnes N; Pavord I; Chuchalin A; Bell J; Hunter M; Lewis T; Parker D; Payton M; Collins LP; Pettipher R; Steiner J; Perkins CM
Clin Exp Allergy; 2012 Jan; 42(1):38-48. PubMed ID: 21762224
[TBL] [Abstract][Full Text] [Related]
73. Ratio of plasma IL-13/TNF- ∝ and CXCL10/CCL17 predicts mepolizumab and omalizumab response in asthma better than eosinophil count or immunoglobulin E level.
Akenroye A; Nopsopon T; Hacker JJ; Laidlaw TM
Sci Rep; 2024 May; 14(1):10404. PubMed ID: 38710930
[TBL] [Abstract][Full Text] [Related]
74. Mepolizumab versus placebo for asthma.
Powell C; Milan SJ; Dwan K; Bax L; Walters N
Cochrane Database Syst Rev; 2015 Jul; (7):CD010834. PubMed ID: 26214266
[TBL] [Abstract][Full Text] [Related]
75. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16.
Kloepfer KM; DeMore JP; Vrtis RF; Swenson CA; Gaworski KL; Bork JA; Evans MD; Gern JE
Ann Allergy Asthma Immunol; 2011 Mar; 106(3):252-7. PubMed ID: 21354028
[TBL] [Abstract][Full Text] [Related]
76. [Effectiveness of mepolizumab in patients with severe eosinophilic asthma: In a real life study].
Bulut İ; Yegin Katran Z; Yavuz D; Yıldız AB; Yakut T; Örçen C; Mersin SS
Tuberk Toraks; 2023 Jun; 71(2):148-155. PubMed ID: 37345397
[TBL] [Abstract][Full Text] [Related]
77. Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline.
Gerday S; Graff S; Moermans C; Guissard F; Paulus V; Henket M; Louis R; Schleich F
Thorax; 2023 Nov; 78(11):1138-1141. PubMed ID: 37657926
[TBL] [Abstract][Full Text] [Related]
78. A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).
Austin CD; Gonzalez Edick M; Ferrando RE; Solon M; Baca M; Mesh K; Bradding P; Gauvreau GM; Sumino K; FitzGerald JM; Israel E; Bjermer L; Bourdin A; Arron JR; Choy DF; Olsson JK; Abreu F; Howard M; Wong K; Cai F; Peng K; Putnam WS; Holweg CTJ; Matthews JG; Kraft M; Woodruff PG;
Clin Exp Allergy; 2020 Dec; 50(12):1342-1351. PubMed ID: 32909660
[TBL] [Abstract][Full Text] [Related]
79. M1-like macrophages are potent producers of anti-viral interferons and M1-associated marker-positive lung macrophages are decreased during rhinovirus-induced asthma exacerbations.
Nikonova A; Khaitov M; Jackson DJ; Traub S; Trujillo-Torralbo MB; Kudlay DA; Dvornikov AS; Del-Rosario A; Valenta R; Stanciu LA; Khaitov R; Johnston SL
EBioMedicine; 2020 Apr; 54():102734. PubMed ID: 32279057
[TBL] [Abstract][Full Text] [Related]
80. A halotyrosine antibody that detects increased protein modifications in asthma patients.
Jin H; Hallstrand TS; Daly DS; Matzke MM; Nair P; Bigelow DJ; Pounds JG; Zangar RC
J Immunol Methods; 2014 Jan; 403(1-2):17-25. PubMed ID: 24295867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
